Skip to content
MedsAcross

Brand family

Lovenox

Enoxaparin · Sanofi-Aventis
United States
Presentations
8
Markets
1

Lovenox is a brand of Enoxaparin marketed by Sanofi-Aventis, with 8 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Enoxaparin
Brand owner
Sanofi-Aventis
Registered in
United States
Strengths and forms
100 mg/1 mL injection, 120 mg/0.8 mL injection, 150 mg/1 mL injection, 30 mg/0.3 mL injection, 300 mg/3 mL injection, 40 mg/0.4 mL injection, 60 mg/0.6 mL injection, 80 mg/0.8 mL injection

All presentations

MedicineManufacturerRegisterAvailability
Lovenox 100 mg/1 mL injectionSubcutaneousSanofi-AventisUS FDAAvailable on request
Lovenox 120 mg/0.8 mL injectionSubcutaneousSanofi-AventisUS FDAAvailable on request
Lovenox 150 mg/1 mL injectionSubcutaneousSanofi-AventisUS FDAAvailable on request
Lovenox 30 mg/0.3 mL injectionSubcutaneousSanofi-AventisUS FDAAvailable on request
Lovenox 300 mg/3 mL injectionIntravenous, subcutaneousSanofi-AventisUS FDAAvailable on request
Lovenox 40 mg/0.4 mL injectionSubcutaneousSanofi-AventisUS FDAAvailable on request
Lovenox 60 mg/0.6 mL injectionSubcutaneousSanofi-AventisUS FDAAvailable on request
Lovenox 80 mg/0.8 mL injectionSubcutaneousSanofi-AventisUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Lovenox

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.